|
🐜
|
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
14 auth.
J. You,
D. Singer,
P. Howard,
D. Lane,
M. Eckman,
M. Fang,
E. Hylek,
S. Schulman,
A. Go,
M. Hughes,
...
F. Spencer,
W. Manning,
J. Halperin,
G. Lip
|
9 |
2012 |
9
🐜
|
|
🦁
|
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.
7 auth.
M. Fang,
A. Go,
Yuchiao Chang,
Leila H. Borowsky,
N. Pomernacki,
N. Udaltsova,
...
D. Singer
|
9 |
2011 |
9
🦁
|
|
🐜
|
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
8 auth.
D. Singer,
G. Albers,
J. Dalen,
M. Fang,
A. Go,
J. Halperin,
...
G. Lip,
W. Manning
|
9 |
2008 |
9
🐜
|
|
🐜
|
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
31 auth.
S. Kimmel,
B. French,
S. Kasner,
Julie A. Johnson,
Jeffrey L. Anderson,
B. Gage,
Y. Rosenberg,
C. Eby,
R. Madigan,
Robert B McBane,
S. Z. Abdel‐Rahman,
S. Stevens,
S. Yale,
E. Mohler,
M. Fang,
...
Vinay Shah,
R. Horenstein,
N. Limdi,
J. Muldowney,
J. Gujral,
P. Delafontaine,
R. Desnick,
T. Ortel,
H. Billett,
R. Pendleton,
N. Geller,
J. Halperin,
S. Goldhaber,
M. Caldwell,
R. Califf,
J. Ellenberg
|
9 |
2013 |
9
🐜
|
|
🐜
|
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
7 auth.
D. Singer,
Yuchiao Chang,
M. Fang,
Leila H. Borowsky,
N. Pomernacki,
N. Udaltsova,
...
A. Go
|
9 |
2009 |
9
🐜
|
|
🦁
|
Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
7 auth.
M. Fang,
Yuchiao Chang,
E. Hylek,
J. Rosand,
S. Greenberg,
A. Go,
...
D. Singer
|
9 |
2004 |
9
🦁
|
|
🦁
|
Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
7 auth.
M. Fang,
A. Go,
Yuchiao Chang,
E. Hylek,
Lori Henault,
Nancy G. Jensvold,
...
D. Singer
|
8 |
2007 |
8
🦁
|
|
🦁
|
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study
7 auth.
M. Fang,
D. Singer,
Yuchiao Chang,
E. Hylek,
Lori Henault,
Nancy G. Jensvold,
...
A. Go
|
8 |
2005 |
8
🦁
|
|
🐜
|
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
7 auth.
A. Go,
M. Fang,
N. Udaltsova,
Yuchiao Chang,
N. Pomernacki,
Leila H. Borowsky,
...
D. Singer
|
8 |
2009 |
8
🐜
|
|
🐜
|
A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score
8 auth.
D. Singer,
Yuchiao Chang,
Leila H. Borowsky,
M. Fang,
N. Pomernacki,
N. Udaltsova,
...
K. Reynolds,
A. Go
|
8 |
2013 |
8
🐜
|
|
🦁
|
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.
M. Fang,
A. Go,
Yuchiao Chang,
Leila H. Borowsky,
N. Pomernacki,
D. Singer
|
8 |
2008 |
8
🦁
|
|
🦁
|
Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study
7 auth.
M. Fang,
A. Go,
E. Hylek,
Yuchiao Chang,
Lori Henault,
Nancy G. Jensvold,
...
D. Singer
|
7 |
2006 |
7
🦁
|
